Bridgeway Capital Management, LLC

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
1,172
Total Value
3970974010
Accession Number
0001085146-25-003239
Form Type
13F-HR
CIK
0001107261
Manager Name
Bridgeway Capital Management, LLC
Data Enrichment
97% identified
1,140 identified32 unidentified

Holdings

1,172 positions
Manager:
SEC
Search and click to pin securities to the top
Page 54 of 59
Purple Innovation, Inc.
PRPL|74640Y106
Shares:
115000(-61.0%)
Value:
$87.3M(-62.0%)
PETMED EXPRESS INC
PETS|716382106
Shares:
20800(-46.7%)
Value:
$87.2M(-53.6%)
VINCE HOLDING CORP.
VNCE|92719W207
Shares:
45256(+0.0%)
Value:
$86.9M(-47.3%)
Vor Biopharma Inc.
VOR|929033108
Shares:
120900(-8.8%)
Value:
$86.7M(-41.1%)
83425V104
DTC|83425V104
Shares:
516926(-33.9%)
Value:
$86.7M(-90.3%)
BIODESIX INC
BDSX|09075X108
Shares:
137011(-65.3%)
Value:
$85.7M(-85.8%)
GSI TECHNOLOGY INC
GSIT|36241U106
Shares:
41717(-54.5%)
Value:
$84.7M(-69.5%)
Co-Diagnostics, Inc.
CODX|189763105
Shares:
272900(+0.0%)
Value:
$84.5M(-58.7%)
Atara Biotherapeutics, Inc.
ATRA|046513206
Shares:
14000(+0.0%)
Value:
$83.2M(-55.4%)
COFFEE HOLDING CO INC
JVA|192176105
Shares:
23369(+9.6%)
Value:
$83.0M(+13.8%)
VYNE Therapeutics Inc.
VYNE|92941V308
Shares:
51958(+40.6%)
Value:
$82.1M(-33.7%)
IO Biotech, Inc.
IOBT|449778109
Shares:
75000(-56.9%)
Value:
$81.8M(-48.9%)
AN2 Therapeutics, Inc.
ANTX|037326105
Shares:
59900(-63.1%)
Value:
$81.5M(-63.6%)
SUPERIOR INDUSTRIES INTERNATIONAL INC
SUP|868168105
Shares:
37600(-64.2%)
Value:
$80.1M(-62.6%)
PepGen Inc.
PEPG|713317105
Shares:
56923(-42.4%)
Value:
$80.0M(-78.7%)
LIVEPERSON INC
LPSN|538146101
Shares:
100000(+0.0%)
Value:
$79.9M(-47.4%)
NOODLES & Co
NDLS|65540B105
Shares:
73152(-50.3%)
Value:
$79.7M(-6.5%)
KRONOS WORLDWIDE INC
KRO|50105F105
Shares:
10625(+2.4%)
Value:
$79.5M(-21.4%)
Pyxis Oncology, Inc.
PYXS|747324101
Shares:
80795(-70.1%)
Value:
$79.2M(-81.2%)
FRACTYL HEALTH, INC.
GUTS|35168W103
Shares:
65500(-52.2%)
Value:
$77.9M(-72.4%)